Clinical evidence from pivotal trials of aPCC in the treatment of haemophilia
Patients with long-standing haemophilia who develop inhibitors to their exogenous coagulation factor therapy derive significant event reduction with activated prothrombin complex concentrate(aPCC)
Learning objectives
You will learn:
- Different types and presentations of haemophilia
- How to treat haemophilia and where to find guidance and support
- The importance of coagulation factor inhibitors and how they affect treatment of haemophilia
- Results from important studies of activated prothrombin complex concentrate (aPCC) in management of haemophilia patients with inhibitors
- The importance of increasing awareness about haemophilia and the availability of Comprehensive Haemophilia Care Centres.
To access this module, please register or login: